The first-in-class antibody-drug conjugate (ADC) pivekimab sunirine (PVEK) demonstrated promising efficacy and high response ...

New research suggests that an antibody-drug conjugate may offer practice-changing, patient-friendly treatment of blastic ...

In patients with an advanced type of skin cancer called cutaneous squamous cell carcinoma (cSCC), those who received the ...

Researchers design a nanovaccine that detects MRSA toxins, kills bacteria with heat, and captures antigens to train the ...

In patients with an advanced type of skin cancer called cutaneous squamous cell carcinoma (cSCC), those who received the ...

This study reveals the potential of engineered phage-IL-12 therapy in melanoma, enhancing immune response and tumor ...

Discover the major highlights from ASCO 2025, according to researchers and drug developers who attended the convention.

For centuries, philosophers and healers alike have speculated about how thoughts, emotions, and consciousness exert tangible ...

People go to great lengths to maintain youthful-looking skin with masks, creams and serums. Now, researchers have discovered ...

A study has revealed why some patients don't respond to immune checkpoint blockade (ICB) therapy for solid cancer tumors and ...

A first-time visit to the dermatologist reveals what really happens during a skin check — plus what to know about rosacea, moles and sun safety.